Document is current
Any future updates will be listed below
-
Authors
Svenningsson, Anna L.
Bocancea, Diana I.
Stomrud, Erik
van Loenhoud, Anita
Barkhof, Frederik
Mattsson-Carlgren, Niklas
Palmqvist, Sebastian
Hansson, Oskar
Ossenkoppele, Rik
-
Funding
Funding for this research was provided by:
Regionalt forskningsstöd (Doktorand-2022-1477)
European Research Council (949570)
European Research Council (949570)
Swedish Research Council (2021-02219)
Swedish Research Council (2018-02052)
Swedish Research Council (2022-00775)
Swedish Brain Foundation (FO2023-0163)
Swedish Brain Foundation (FO2022-0204)
Swedish Brain Foundation (FO2021-0293)
National Institute of Aging (R01AG083740)
National Council for Eurasian and East European Research (ADG-101096455)
Lund University
- License Information
-
More Information
Article History
Received: 14 February 2024
Accepted: 29 September 2024
First Online: 12 October 2024
Declarations
:
: The study was approved by the ethics committee at Lund University and the participants gave their written informed consent. The study procedure was conducted according to the Helsinki.
: Not applicable.
: OH has acquired research support (for the institution) from AVID Radiopharmaceuticals, Biogen, C2N Diagnostics, Eli Lilly, Eisai, Fujirebio, GE Healthcare, and Roche. In the past 2 years, he has received consultancy/speaker fees from AC Immune, Alzpath, BioArctic, Biogen, Bristol Meyer Squibb, Cerveau, Eisai, Eli Lilly, Fujirebio, Merck, Novartis, Novo Nordisk, Roche, Sanofi and Siemens. SP has acquired research support (for the institution) from ki elements / ADDF and Avid. In the past 2 years, he has received consultancy/speaker fees from Bioartic, Biogen, Esai, Lilly, and Roche. All other authors report no competing interests.
